Funder
AstraZeneca Nordic Baltic, Sweden
Svend Andersen Fonden
Reference39 articles.
1. Opioid-induced bowel dysfunction: pathophysiology and management;Brock;Drugs,2012
2. Absorption, distribution, metabolism, and excretion of [14C]-labeled naloxegol in healthy subjects;Bui;Int. J. Clin. Pharmacol. Ther.,2015
3. Topographic and manometric characterization of the recto-anal inhibitory reflex;Cheeney;Neurogastroenterol. Motil.,2012
4. Naloxegol for opioid-induced constipation in patients with noncancer pain. PRA International Salt Lake City (L.W.); AstraZeneca Pharm;Chey;N. Engl. J. Med.,2014
5. Effects of glucagon and secretin on food- or morphine-induced motor activity of the distal colon, rectum, and anal sphincter;Chowdhury;Am J Dig Dis,1977
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献